Molecularly Targeted Agents as Radiosensitizers in Cancer Therapy—Focus on Prostate Cancer
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Molecularly Targeted Agents as Radiosensitizers in Cancer Therapy—Focus on Prostate Cancer
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 14, Issue 7, Pages 14800-14832
Publisher
MDPI AG
Online
2013-07-17
DOI
10.3390/ijms140714800
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hsp90 Inhibitors NVP-AUY922 and NVP-BEP800 May Exert a Significant Radiosensitization on Tumor Cells along with a Cell Type-Specific Cytotoxicity
- (2014) Natalia Niewidok et al. Translational Oncology
- Comparative Evaluation of Radiation Treatments for Clinically Localized Prostate Cancer: An Updated Systematic Review
- (2013) Raveendhara R. Bannuru et al. ANNALS OF INTERNAL MEDICINE
- Novel Hsp90 inhibitor NVP-AUY922 radiosensitizes prostate cancer cells
- (2013) Nishant Gandhi et al. CANCER BIOLOGY & THERAPY
- Animal Models of Human Prostate Cancer: The Consensus Report of the New York Meeting of the Mouse Models of Human Cancers Consortium Prostate Pathology Committee
- (2013) M. Ittmann et al. CANCER RESEARCH
- The PI3K/Akt signaling pathway regulates the expression of Hsp70, which critically contributes to Hsp90-chaperone function and tumor cell survival in multiple myeloma
- (2013) M. Chatterjee et al. HAEMATOLOGICA
- Sunitinib Plus Androgen Deprivation and Radiation Therapy for Patients With Localized High-Risk Prostate Cancer: Results From a Multi-institutional Phase 1 Study
- (2013) Paul G. Corn et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Opportunities and Challenges in the Era of Molecularly Targeted Agents and Radiation Therapy
- (2013) Steven H. Lin et al. JNCI-Journal of the National Cancer Institute
- Combining Radiotherapy and Cancer Immunotherapy: A Paradigm Shift
- (2013) Silvia C. Formenti et al. JNCI-Journal of the National Cancer Institute
- Radiosensitization of prostate cancer cells by the dual PI3K/mTOR inhibitor BEZ235 under normoxic and hypoxic conditions
- (2013) Vincent A. Potiron et al. RADIOTHERAPY AND ONCOLOGY
- Radiosensitization in prostate cancer: mechanisms and targets
- (2013) Diego A Palacios et al. BMC Urology
- Targeting the androgen receptor signalling axis in castration-resistant prostate cancer (CRPC)
- (2012) Che-Kai Tsao et al. BJU INTERNATIONAL
- Tissue Biomarkers for Prostate Cancer Radiation Therapy
- (2012) P. T. Tran et al. CURRENT MOLECULAR MEDICINE
- The Clinical Development of Molecularly Targeted Agents in Combination With Radiation Therapy: A Pharmaceutical Perspective
- (2012) Ozlem U. Ataman et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Biodistribution, Tumor Detection, and Radiation Dosimetry of 18F-DCFBC, a Low-Molecular-Weight Inhibitor of Prostate-Specific Membrane Antigen, in Patients with Metastatic Prostate Cancer
- (2012) S. Y. Cho et al. JOURNAL OF NUCLEAR MEDICINE
- NCI–RTOG Translational Program Strategic Guidelines for the Early-Stage Development of Radiosensitizers
- (2012) Yaacov Richard Lawrence et al. JNCI-Journal of the National Cancer Institute
- Chk1 knockdown confers radiosensitization in prostate cancer stem cells
- (2012) XIAOBIN WANG et al. ONCOLOGY REPORTS
- The HSP90 Inhibitor NVP-AUY922 Radiosensitizes by Abrogation of Homologous Recombination Resulting in Mitotic Entry with Unresolved DNA Damage
- (2012) Shane Zaidi et al. PLoS One
- Preclinical evaluation of sunitinib, a multi-tyrosine kinase inhibitor, as a radiosensitizer for human prostate cancer
- (2012) Colin Brooks et al. Radiation Oncology
- Dasatinib, a multi-kinase inhibitor increased radiation sensitivity by interfering with nuclear localization of epidermal growth factor receptor and by blocking DNA repair pathways
- (2012) Uma Raju et al. RADIOTHERAPY AND ONCOLOGY
- Radiosensitizing effect of the novel Hsp90 inhibitor NVP-AUY922 in human tumour cell lines silenced for Hsp90α
- (2012) L. Stingl et al. STRAHLENTHERAPIE UND ONKOLOGIE
- Twist1 Suppresses Senescence Programs and Thereby Accelerates and Maintains Mutant Kras-Induced Lung Tumorigenesis
- (2012) Phuoc T. Tran et al. PLoS Genetics
- Radiotherapy combined with hormonal therapy in prostate cancer: the state of the art
- (2012) Piotr Milecki Cancer Management and Research
- A Phase I Study of Dasatinib with Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer
- (2012) Humera Khurshid et al. Frontiers in Oncology
- Guidelines for preclinical and early phase clinical assessment of novel radiosensitisers
- (2011) K J Harrington et al. BRITISH JOURNAL OF CANCER
- Effects of lapatinib monotherapy: results of a randomised phase II study in therapy-naive patients with locally advanced squamous cell carcinoma of the head and neck
- (2011) J M del Campo et al. BRITISH JOURNAL OF CANCER
- Dasatinib combined with docetaxel for castration-resistant prostate cancer
- (2011) John C. Araujo et al. CANCER
- Reciprocal Feedback Regulation of PI3K and Androgen Receptor Signaling in PTEN-Deficient Prostate Cancer
- (2011) Brett S. Carver et al. CANCER CELL
- MRE11 promotes AKT phosphorylation in direct response to DNA double-strand breaks
- (2011) Michael Fraser et al. CELL CYCLE
- Impact of the SRC inhibitor dasatinib on the metastatic phenotype of human prostate cancer cells
- (2011) Lori Rice et al. CLINICAL & EXPERIMENTAL METASTASIS
- 2-(3- -Ureido)-Pentanedioic Acid, [18F]DCFPyL, a PSMA-Based PET Imaging Agent for Prostate Cancer
- (2011) Y. Chen et al. CLINICAL CANCER RESEARCH
- mTOR is a selective effector of the radiation therapy response in androgen receptor-positive prostate cancer
- (2011) Matthew J Schiewer et al. ENDOCRINE-RELATED CANCER
- Phase II Study of Long-Term Androgen Suppression With Bevacizumab and Intensity-Modulated Radiation Therapy (IMRT) in High-Risk Prostate Cancer
- (2011) Jacqueline Vuky et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Prostate-targeted radiosensitization via aptamer-shRNA chimeras in human tumor xenografts
- (2011) Xiaohua Ni et al. JOURNAL OF CLINICAL INVESTIGATION
- Strong anti-tumor effect of NVP-AUY922, a novel Hsp90 inhibitor, on non-small cell lung cancer
- (2011) Tsuyoshi Ueno et al. LUNG CANCER
- Hsp90 Inhibitor-Mediated Disruption of Chaperone Association of ATR with Hsp90 Sensitizes Cancer Cells to DNA Damage
- (2011) K. Ha et al. MOLECULAR CANCER THERAPEUTICS
- Ganetespib, a Unique Triazolone-Containing Hsp90 Inhibitor, Exhibits Potent Antitumor Activity and a Superior Safety Profile for Cancer Therapy
- (2011) W. Ying et al. MOLECULAR CANCER THERAPEUTICS
- Expanding Treatment Options for Metastatic Prostate Cancer
- (2011) Emmanuel S. Antonarakis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Radiotherapy and Short-Term Androgen Deprivation for Localized Prostate Cancer
- (2011) Christopher U. Jones et al. NEW ENGLAND JOURNAL OF MEDICINE
- Noninvasive measurement of androgen receptor signaling with a positron-emitting radiopharmaceutical that targets prostate-specific membrane antigen
- (2011) M. J. Evans et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Principles and Applications of Diffusion-weighted Imaging in Cancer Detection, Staging, and Treatment Follow-up
- (2011) Ashkan A. Malayeri et al. RADIOGRAPHICS
- Detection of Recurrent Prostate Carcinoma withanti-1-Amino-3-18F-Fluorocyclobutane-1-Carboxylic Acid PET/CT and111In–Capromab Pendetide SPECT/CT
- (2011) David M. Schuster et al. RADIOLOGY
- Practical modifications to the time-to-event continual reassessment method for phase I cancer trials with fast patient accrual and late-onset toxicities
- (2011) Mei-Yin C. Polley STATISTICS IN MEDICINE
- Targeting heat shock proteins in cancer
- (2010) Gaëtan Jego et al. CANCER LETTERS
- Modulating Tumor Vasculature through Signaling Inhibition to Improve Cytotoxic Therapy
- (2010) A. Maity et al. CANCER RESEARCH
- Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
- (2010) T.-C. Chou CANCER RESEARCH
- An Overview of the Optimal Planning, Design, and Conduct of Phase I Studies of New Therapeutics
- (2010) P. M. LoRusso et al. CLINICAL CANCER RESEARCH
- The Design of Phase II Clinical Trials Testing Cancer Therapeutics: Consensus Recommendations from the Clinical Trial Design Task Force of the National Cancer Institute Investigational Drug Steering Committee
- (2010) L. Seymour et al. CLINICAL CANCER RESEARCH
- Sorafenib and Radiation: A Promising Combination in Colorectal Cancer
- (2010) Andrew W. Suen et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Pharmacokinetic Assessment of the Uptake of 16 -18F-Fluoro-5 -Dihydrotestosterone (FDHT) in Prostate Tumors as Measured by PET
- (2010) B. J. Beattie et al. JOURNAL OF NUCLEAR MEDICINE
- RTOG 0017: A Phase I Trial of Concurrent Gemcitabine/Carboplatin or Gemcitabine/Paclitaxel and Radiation Therapy (“Ping-Pong Trial”) Followed By Adjuvant Chemotherapy for Patients with Favorable Prognosis Inoperable Stage IIIA/B Non-small Cell Lung Cancer
- (2010) Hak Choy et al. Journal of Thoracic Oncology
- The Src Inhibitor AZD0530 Blocks Invasion and May Act as a Radiosensitizer in Lung Cancer Cells
- (2010) Phillip R. Purnell et al. Journal of Thoracic Oncology
- Randomized Phase II Trials: Time for a New Era in Clinical Trial Design
- (2010) Sumithra J. Mandrekar et al. Journal of Thoracic Oncology
- External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study
- (2010) Michel Bolla et al. LANCET ONCOLOGY
- Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction
- (2009) Ji Luo et al. CELL
- Phase II Study of Dasatinib in Patients with Metastatic Castration-Resistant Prostate Cancer
- (2009) E. Y. Yu et al. CLINICAL CANCER RESEARCH
- Hypoxia and Radiation Therapy: Past History, Ongoing Research, and Future Promise
- (2009) Sara Rockwell et al. CURRENT MOLECULAR MEDICINE
- How Much Is Life Worth: Cetuximab, Non-Small Cell Lung Cancer, and the $440 Billion Question
- (2009) T. Fojo et al. JNCI-Journal of the National Cancer Institute
- NVP-AUY922: A Novel Heat Shock Protein 90 Inhibitor Active against Xenograft Tumor Growth, Angiogenesis, and Metastasis
- (2008) S. A. Eccles et al. CANCER RESEARCH
- Phase II Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients with Metastatic Melanoma
- (2008) D. B. Solit et al. CLINICAL CANCER RESEARCH
- N-[N-[(S)-1,3-Dicarboxypropyl]Carbamoyl]-4-[18F]Fluorobenzyl-L-Cysteine, [18F]DCFBC: A New Imaging Probe for Prostate Cancer
- (2008) R. C. Mease et al. CLINICAL CANCER RESEARCH
- Enhanced In vitro and In vivo Cytotoxicity of Combined Reovirus and Radiotherapy
- (2008) K. Twigger et al. CLINICAL CANCER RESEARCH
- Phase 0 clinical trials: Recommendations from the task force on methodology for the development of innovative cancer therapies
- (2008) Shivaani Kummar et al. EUROPEAN JOURNAL OF CANCER
- SU11248 (Sunitinib) Sensitizes Pancreatic Cancer to the Cytotoxic Effects of Ionizing Radiation
- (2008) Kyle C. Cuneo et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- High-Resolution, Small Animal Radiation Research Platform With X-Ray Tomographic Guidance Capabilities
- (2008) John Wong et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Update of Dutch Multicenter Dose-Escalation Trial of Radiotherapy for Localized Prostate Cancer
- (2008) Abrahim Al-Mamgani et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Final Report of Multicenter Canadian Phase III Randomized Trial of 3 Versus 8 Months of Neoadjuvant Androgen Deprivation Therapy Before Conventional-Dose Radiotherapy for Clinically Localized Prostate Cancer
- (2008) Juanita Crook et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Androgen Suppression and Radiation vs Radiation Alone for Prostate Cancer
- (2008) Anthony V. D’Amico et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- In VivoAnalysis of Protein Kinase B (PKB)/Akt Regulation in DNA-PKcs-null Mice Reveals a Role for PKB/Akt in DNA Damage Response and Tumorigenesis
- (2008) Banu Surucu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Short-Term Neoadjuvant Androgen Deprivation Therapy and External-Beam Radiotherapy for Locally Advanced Prostate Cancer: Long-Term Results of RTOG 8610
- (2008) Mack Roach et al. JOURNAL OF CLINICAL ONCOLOGY
- Ten-Year Follow-Up of Radiation Therapy Oncology Group Protocol 92-02: A Phase III Trial of the Duration of Elective Androgen Deprivation in Locally Advanced Prostate Cancer
- (2008) Eric M. Horwitz et al. JOURNAL OF CLINICAL ONCOLOGY
- Structural Studies on the Co-chaperone Hop and Its Complexes with Hsp90
- (2008) S.C. Onuoha et al. JOURNAL OF MOLECULAR BIOLOGY
- PKBα/Akt1 Acts Downstream of DNA-PK in the DNA Double-Strand Break Response and Promotes Survival
- (2008) Lana Bozulic et al. MOLECULAR CELL
- Geldanamycin promotes premature mitotic entry and micronucleation in irradiated p53/p21 deficient colon carcinoma cells
- (2008) D M Moran et al. ONCOGENE
- Is there a role for positron emission tomography imaging in the early evaluation of prostate cancer relapse?
- (2008) C Greco et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Long-Term Results of the M. D. Anderson Randomized Dose-Escalation Trial for Prostate Cancer
- (2007) Deborah A. Kuban et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started